A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lynda Vrooman, MD
Dana-Farber Cancer Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mcmasters University Medical Center
Hamilton, Ontario, Canada
- Sick Children'S Hospital
Toronto, Ontario, Canada
- Hospital St. Justine
Saint Catherine, Quebec, Canada
- Quebec Children'S Hospital
Sainte-Foy, Quebec, Canada
- Children'S Hospital of Los Angeles
Los Angeles, California, United States
- Children'S Hospital of Orange County
Orange County, California, United States
- Stanford Medical Center
Palo Alto, California, United States
- Children'S Hospital
Aurora, Colorado, United States
- All Children'S Hospital
St. Petersburg, Florida, United States
- Children'S Memorial Hospital
Chicago, Illinois, United States
- John Hopkins
Baltimore, Maryland, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- University of Minnesota
Minneapolis, Michigan, United States
- Children'S Hospital and Clinics of Minnesota
Minneapolis, Minnesota, United States
- Umdnj/robert Wood Johnson
New Brunswick, New Jersey, United States
- Columbia Presbyterian Medical Center
New York, New York, United States
- Montifiore Medical Center
The Bronx, New York, United States
- Oregon Health & Sciences
Portland, Oregon, United States
- Children'S Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Texas Children'S Hospital
Houston, Texas, United States
- Inova Fairfax Medical Center
Falls Church, Virginia, United States
- Children'S Hospital of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2012
- Primary completion
- 31 Aug 2013
- Completion
- 31 Dec 2013
- Last update posted
- 23 Jun 2021
- Registered enrollment
- 30
- Registry id
- NCT01643408
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.